Shilong Zheng

Molecular Biology · 2015

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Shilong Zheng trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. PA Marks
  2. Ricky W. Johnstone

Papers from Shilong Zheng's perspective

Ordered by how strongly the researchers Shilong Zheng trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. (Structure)
  2. Anticancer activities of histone deacetylase inhibitors (Nature reviews. Drug discovery)
  3. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes (Nature Medicine)
  4. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. (Biochemical and Biophysical Research Communications - BBRC)
  5. Histone Deacetylase Inhibitors for Cancer Therapy (Epigenetics)
  6. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). (Blood)
  7. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. (Proceedings of the National Academy of Sciences of the United States of America)
  8. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. (Journal of Molecular Biology)
  9. Histone deacetylase inhibitors. (European journal of medicinal chemistry)
  10. Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. (Journal of Clinical Oncology)

Their papers